MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

CE Mark Awarded for New Image-Guided Radiation Therapy Platform

By MedImaging International staff writers
Posted on 31 Aug 2016
Print article
Image: The new Radixact system next-generation image-guided radiation therapy platform (Photo courtesy of Accuray).
Image: The new Radixact system next-generation image-guided radiation therapy platform (Photo courtesy of Accuray).
A radiation oncology company has announced that its next-generation image-guided radiation therapy platform, with integrated software, has been awarded the CE Mark (Conformité Européenne) and is now available in the EU.

The system received US FDA 510(k) clearance in June 2016, and is faster, and easier to use than existing tomotherapy systems provided by the company.

The new Radixact platform was developed by Accuray (Sunnyvale, CA) and includes the Radixact Treatment Delivery System, the Accuray Precision Treatment Planning System, and the iDMS Data Management System. The Radixact system features a more powerful linear accelerator and is intended for the treatment of cancer patients. The system features MVCT imaging, and helical treatment delivery for more precise and homogeneous radiation dose distribution sparing healthy tissue.

The Accuray Precision Treatment Planning System provides automated workflows and decision-making tools that help clinicians adjust the delivery of radiotherapy treatment according to changes in the size, shape and location of a tumor.

Joshua H. Levine, president and CEO, Accuray, said, “Radixact System availability in the EU is a critical component of our commercial launch strategy for this innovative platform. We have shipped the first commercially released Radixact System to a site in the US and expect our first EU shipment during our Fiscal Q1 2017. The system is a key driver of our short- and long-term growth outlook, as well as our ability to achieve sustainable profitability, and we are excited about the reception the system is receiving in the marketplace.”

Related Links:
Accuray

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound System
Acclarix AX9
New
Pre-Op Planning Solution
Sectra 3D Trauma
New
X-Ray Detector
FDR-D-EVO III

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)

New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients

Clear cell renal cell cancer (ccRCC) represents 70-80% of renal cell carcinoma cases. While localized disease can be effectively treated with surgery and ablative therapies, one-third of patients either... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more